In this article, we are going to discuss the 12 high yield Fortune 500 stocks to buy now.
The 2026 Fortune 500 rankings dropped earlier this month, and it showed that collectively, these companies pulled in $21 trillion in revenue, a 5% increase from last year, while profits climbed a steeper 12% to hit $2.1 trillion. Their combined market value now stands at $55 trillion, nearly a fifth more than it was a year ago. To put that in perspective, these 500 companies account for roughly two-thirds of everything the US economy produces, and they employ 30.5 million people worldwide.
The biggest shake-up at the top: Amazon has replaced Walmart from the No. 1 spot after 13 straight years. It is worth remembering that Amazon first cracked this list back in 2002, sitting at No. 492. Walmart, meanwhile, settles into second place, a ranking it has not occupied since 2012.
Power, however, is increasingly concentrated at the very top. Alphabet, Nvidia, Apple, and Meta each crossed $100 billion in profits individually, together accounting for $466 billion, or about 22 cents of every dollar the entire Fortune 500 earned.
On the leadership front, a record 55 Fortune 500 companies are now led by women. That is 11% of the list, and the fourth consecutive year that the share has held at or above that mark.
With that said, here are the Best Fortune 500 Dividends Stocks to Buy in 2026.
Photo by Viacheslav Bublyk on Unsplash
Our Methodology
To collect data for this article, we scanned the top companies among the Fortune Global Rankings and shortlisted dividend stocks with an annual yield of at least 2.50%, as of June 11. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. The following are the Best Fortune 500 Dividend Stocks to Buy Now.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
12. International Business Machines Corporation (NYSE:IBM)
Dividend Yield as of June 11: 2.50%
International Business Machines Corporation (NYSE:IBM) is a provider of global hybrid cloud and AI and consulting expertise.
On June 8, BofA analyst Wamsi Mohan boosted the firm’s price target on International Business Machines Corporation from $300 to $315, while keeping a ‘Buy’ rating on the shares. The revised objective represents an upside of over 15% from the current share price.
BofA believes that the demand for AI infrastructure continues to be broader, deeper, and more durable. The analyst firm raised its price targets on several tech stocks following the bullish sentiment surrounding the strong long-term demand trends expressed by industry experts at the BofA 2026 Global Technology Conference.
International Business Machines Corporation continues to bolster its position in cutting-edge technologies and disclosed last month that it would invest $10 billion into quantum computing over the next five years. The move follows a letter of intent between the company and the US federal government to build a quantum chip foundry in the country. IBM also revealed that it would put $5 billion towards an AI-linked open-source software project.
11. CVS Health Corporation (NYSE:CVS)
Dividend Yield as of June 11: 2.65%
America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness.
On June 8, Mizuho upped its price target on CVS Health Corporation from $110 to $115, and maintained its ‘Outperform’ rating on the shares. The revised target indicates an upside of over 14% from the current price level.
According to Mizuho, the managed care industry is going into a “more stable and predictable” policy backdrop. The analyst firm believes that the severity and frequency of policy-related surprises should ease down from the unusually high levels seen over the past three years. This should allow investors to focus on the company fundamentals, pricing recovery, and the underlying earnings potential of the overall sector.
As a result, Mizuho boosted its price targets across the managed care sector to reflect the more stable regulatory and legislative environment.
CVS Health Corporation has grown its dividends by 56.5% over the last decade and boasts an impressive annual yield of 2.65%. This makes it especially attractive for institutional investors and puts it among the 12 Best Dividend Stocks to Invest In According to Hedge Funds.
10. The Toronto-Dominion Bank (NYSE:TD)
Dividend Yield as of June 11: 2.80%
The Toronto-Dominion Bank (NYSE:TD) and its subsidiaries are collectively known as TD Bank Group (TD). TD is the sixth largest bank in North America by assets and serves around 28 million customers in a number of locations in key financial centres around the globe.
On June 1, RBC Capital upped its price target on The Toronto-Dominion Bank from C$138 to C$156, while maintaining an ‘Outperform’ rating on the shares.
Similarly, on the same day, the analysts over at Scotiabank also raised the firm’s price target on The Toronto-Dominion Bank from C$150 to C$165, while keeping an ‘Outperform’ rating on the shares. The target boost reflects an upside of over 3% from the current price level.
The bullish sentiment comes after TD exceeded expectations in its Q2 report on May 28, helped by the robust performance at its Canadian personal and commercial banking, wealth, and wholesale banking units. The company delivered record Q2 earnings in Canadian Personal and Commercial Banking, all-time high earnings in Wealth Management and Insurance and Wholesale Banking, and also achieved accelerated momentum in US Banking.
The Toronto-Dominion Bank also raised its quarterly dividend by 3.7% to C$1.12 per share, payable on July 31 to shareholders as of the July 10 record. The stock currently boasts an impressive annual dividend yield of 2.80%.
9. Amgen Inc. (NASDAQ:AMGN)
Dividend Yield as of June 11: 2.85%
Amgen Inc. (NASDAQ:AMGN) discovers, develops, manufactures, and delivers innovative medicines to fight some of the world’s toughest diseases.
On June 10, Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen Inc. from $322 to $340, while keeping an ‘Equal Weight’ rating on the shares. The boosted price goal still indicates a downside of over 4% from the current levels.
The US Food and Drug Administration (FDA) approved Amgen’s Uplizna as the first treatment for adults living with Immunoglobulin G4-related disease (IgG4-RD) last year. The drug was later also approved by the European Commission as an add-on treatment to standard therapy for adults living with generalized myasthenia gravis (gMG) in February 2026.
Morgan Stanley noted that the launch of Uplizna for generalized myasthenia gravis (gMG) is “off to a strong start”. The firm believes that the gMG market has the potential to double to over $10 billion over the next five or so years, fueled by the introduction of new therapies and the rising adoption of biologics.
8. NIKE, Inc. (NYSE:NKE)
Dividend Yield as of June 11: 3.57%
NIKE, Inc. (NYSE:NKE) is engaged in the designing, marketing, and distribution of athletic footwear, apparel, equipment, and accessories and services for sports and fitness activities.
On June 10, RBC Capital analyst Piral Dadhania downgraded NIKE, Inc. from ‘Outperform’ to ‘Sector Perform’, while also cutting the firm’s price target on the stock from $70 to $50. The lowered target still indicates an upside of almost 14% from the current levels.
According to RBC, Nike’s turnaround under the leadership of CEO Elliott Hill is making progress, but it is “slower and narrower” than expected. The firm believes that while the upcoming FIFA World Cup and Nike’s “ongoing clean up activities” provide some support, the company lacks enough growth engines to deliver a sustained improvement in sales trends throughout 2026. As a result, the analyst firm sees a limited upside for the stock in the near term.
After reducing its earnings estimates below consensus, RBC believes that NIKE, Inc. valuation appears stretched compared to the growth prospects of its peers.
7. Medtronic plc (NYSE:MDT)
Dividend Yield as of June 11: 3.59%
Next on our list of the Best Fortune 500 Dividend Stocks is Medtronic plc (NYSE:MDT). The company develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
On June 5, Bernstein analyst Lee Hambright lowered the firm’s price target on Medtronic plc (NYSE:MDT) from $112 to $97, but maintained an ‘Outperform’ rating on the shares. The trimmed target, which still represents an upside of over 21% from the current levels, comes following the company’s solid Q4 2026 report on June 3.
Medtronic plc (NYSE:MDT) exceeded Wall Street expectations in both profits and revenue in the fourth quarter, buoyed by the steady demand for its heart devices used in complex cardiac procedures. The company’s Cardiac Ablation Solutions revenue surged by 78% globally, including 124% growth in the United States, which increased its market share in the country by 8 points.
Medtronic plc (NYSE:MDT) is targeting organic revenue growth of 6.75% to 7.25% in FY 2027, including approximately 11.5% to 12% organic growth in the first quarter. This compares to a YoY growth of 5.8% in FY26. Moreover, the company is expecting an adjusted annual profit in the range of $5.90 to $6 per share for the coming year, below the $6.06 per share analysts were projecting.
Medtronic plc (NYSE:MDT) also declared a quarterly dividend of $0.72 per share, up 1.4% from its prior dividend of $0.71. The dividend is payable on June 17 to shareholders as of the June 26 record.
After a softer EPS growth over the last four years, Bernstein wants to see Medtronic overcome EPS headwinds and deliver better than its guidance.
6. Rio Tinto Group (NYSE:RIO)
Dividend Yield as of June 11: 3.88%
Rio Tinto Group (NYSE:RIO) engages in exploring, mining, and processing mineral resources worldwide. The company operates through its Iron Ore, Aluminium, Lithium, and Copper segments.
On June 8, Citi lifted its price target on Rio Tinto Group from £7,600 to £8,100, but maintained a ‘Neutral’ rating on the shares. The revised target indicates an upside of more than 6% from the current share price.
On the other hand, RBC Capital turned bearish on Rio Tinto Group on June 3 when its analyst Ben Davis downgraded the stock from ‘Sector Perform’ to ‘Outperform’, while also cutting the stock’s price target from £6,400 to £6,300.
RIO had posted YTD gains of over 37% until June 2, and the downgrade was motivated by valuation concerns following the stock’s rally. According to RBC Capital, Rio Tinto’s share price now reflects the “supportive” aluminum market conditions, “resilient” margins in the Pilbara iron ore operations in Australia, and effective execution across the company’s major growth projects.
While the analyst firm remains bullish on the outlook for copper and aluminum, it believes that much of the expected improvement in Rio’s EBITDA and free cash flow is already reflected in its stock price, leaving more room for downside surprises at current valuation levels.
5. PepsiCo, Inc. (NASDAQ:PEP)
Dividend Yield as of June 11: 4.12%
PepsiCo, Inc. (NASDAQ:PEP) engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide.
On June 5, Wells Fargo trimmed its price target on PepsiCo, Inc. from $160 to $150, but maintained an ‘Equal Weight’ rating on the shares. The lowered target still indicates an upside of 4% from the current price level.
Wells Fargo cited ongoing macroeconomic uncertainty, which is likely to have an impact on consumer spending and therefore PepsiCo’s product categories. While the analyst firm acknowledges that Pepsi’s execution has been good in certain areas, especially within its Food segment, it believes that the company’s goal of accelerating sales growth through 2026 may be tough to achieve. According to Wells, the debate around PepsiCo’s long-term growth prospects in North America is likely to persist.
PepsiCo, Inc. topped Wall Street estimates in its Q1 2026 report in April, supported by its price cuts for salty snacks in the US and the strong demand for diet sodas. The company also reaffirmed its guidance for FY 2026, with the company projecting organic revenue to rise between 2% and 4% and core constant currency EPS to grow 4% to 6% compared to last year.
PepsiCo, Inc. boasts an annual dividend yield of 4.12%, putting it among the 10 Best Dividend-Paying Beverage Stocks to Buy Now.
4. HP Inc. (NYSE:HPQ)
Dividend Yield as of June 11: 4.86%
HP Inc. (NYSE:HPQ) provides personal computing, printing, 3D printing, hybrid work, gaming, and other related technologies in the United States and internationally.
On June 2, Goldman Sachs raised the firm’s price target on HP Inc. from $16 to $19, but maintained its ‘Sell’ rating on the shares. The revised target, which still indicates a downside of over 23% from the current levels, comes following the tech company’s Q2 report on May 27.
The analyst firm remains cautious regarding HP’s outlook, citing the significant increases in the company’s input costs and the high competition in the PC market. According to Goldman, it is still uncertain if HP’s efforts to improve its product mix, price increases, and additional supply chain mitigation measures will be enough to offset the broader industry headwinds during the latter half of this year and throughout 2027.
HP Inc. topped profit and revenue estimates in its Q1 report last month, supported by the robust demand for AI-optimized personal computers. However, the company warned that it expects the rising input costs to put increasing pressure on its operating margins, particularly in Personal Systems.
3. British American Tobacco plc (NYSE:BTI)
Dividend Yield as of June 11: 5.34%
British American Tobacco plc (NYSE:BTI) is a leading multi-category consumer goods company that provides tobacco and nicotine products to millions of consumers around the world.
On June 8, Morgan Stanley analyst Rashad Kawan boosted the firm’s price objective on British American Tobacco plc (NYSE:BTI) from £4,900 to £4,950, while maintaining an ‘Overweight’ rating on the shares. The revised target reflects an upside of over 7% from the current share price.
British American Tobacco plc (NYSE:BTI) sells a wide range of products, including vaporizers, chewing tobacco, and heated tobacco, but the majority of the company’s revenue still comes from cigarettes. However, with a large number of consumers now moving away from smoking, BAT is having to transition to next-gen products, including nicotine pouches, which have emerged as the fastest-growing segment within new categories. The business witnessed a 47% rise in sales volume in 2025.
British American Tobacco plc (NYSE:BTI) also offers an attractive annual dividend yield of 5.34%, and its high operating profit margin, which came in at 44% on an adjusted basis last year, helps to ensure the reliability of the high payout.
2. Verizon Communications Inc. (NYSE:VZ)
Dividend Yield as of June 11: 6.03%
Verizon Communications Inc. (NYSE:VZ) engages in the provision of communications, technology, information, and streaming products and services to consumers, businesses, and governmental entities worldwide.
On June 5, Verizon Communications Inc. declared a quarterly dividend of $0.7075 per share. The dividend is payable on August 3 to shareholders of record July 10. Verizon made approximately $11.5 billion in cash dividend payments in 2025 and boasts a robust annual yield of 6.03%. The company has grown its dividend for 20 consecutive years, putting it among the 15 Best Dividend Paying Stocks to Buy Right Now.
Dan Schulman, CEO of Verizon Communications Inc., commented:
“Verizon’s commitment to the dividend remains ironclad and is a direct reflection of our focus on long-term shareholder value. Through our ongoing transformation, we continue to prioritize building trust, delighting our customers, and staying disciplined with our capital allocation strategy. Twenty consecutive years of dividend increases is a track record we’re extremely proud of and one that reflects the cash-generating nature of our business.”
According to market strategist Kenny Polcari, while Verizon may never resemble a high-growth tech stock, it appeals to income-oriented portfolios due to its highly predictable cash flows, essential services exposure, and durable income generation that investors value in periods of high volatility.
1. Pfizer Inc. (NYSE:PFE)
Dividend Yield as of June 11: 6.57%
Topping our list of the Best Fortune 500 Dividend Stocks is Pfizer Inc. (NYSE:PFE). The company discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer health care products.
On June 10, Pfizer Inc. was upgraded by RBC Capital analyst Trung Huynh from ‘Underperform’ to ‘Sector Perform’. Mr. Huynh assigned the stock a price target of $25, indicating a downside of 5% from the current levels.
RBC noted that its overall investment outlook on Pfizer has not substantially changed. However, with the stock down by over 8% from its highs earlier this year and now trading at around 9-times forward earnings, the analyst firm believes that it offers a more balanced risk-reward profile.
RBC also highlighted two key catalysts for Pfizer – Sigvotatug vedotin in second-line lung cancer in mid-2026 and mevro in the latter half of this year. Moreover, the analyst highlighted the pharma company’s strong Q1 fundamentals that should support a potential 2026 guidance upgrade, as well as its robust dividend yield of 6.57%, which may help limit downside risk.
READ NEXT: 10 High Yield Crude Oil Stocks to Buy Now and 10 Most Volatile Stocks to Buy in S&P 500
Hedge Fund Resource Center